XFOR Market Cap History

Below is a table of the XFOR market cap history going back to 3/14/2019:

Date XFOR Market Cap

Also see: XFOR Shares Outstanding History
and XFOR YTD Return
XFOR Historical Market Cap:
+38.45% CAGR
XFOR Historical Market Cap: +38.45% CAGR

Mouse over chart for data details
3/14/2019 ...5/3/2024
X4 PHARMACEUTICALS is a biopharmaceutical company. Co.'s primary clinical candidate is mavorixafor, a small molecule antagonist of chemokine receptor C-X-C receptor type 4, that is being developed as an oral, once-daily therapy. Due to its ability to increase the mobilization of mature, functional white blood cells from the bone marrow into the bloodstream, mavorixafor has the potential to provide therapeutic benefit across a variety of neutropenic disorders, including Warts, Hypogammaglobulinemia, Infections, and Myelokathexis syndrome, a rare, primary immunodeficiency. Co. is also developing mavorixafor in a Phase 2 clinical trial in people with certain neutropenic disorders. We show 22 historical shares outstanding datapoints in our XFOR shares outstanding history coverage, used to compute XFOR market cap on those dates.

Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing XFOR market cap history over the course of time is important for investors interested in comparing XFOR's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of XFOR versus a peer is one thing; comparing XFOR market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like XFOR can fluctuate over the course of history. With this page we aim to empower investors researching XFOR by allowing them to research the XFOR market cap history.
Quotes delayed 20 minutes

Email EnvelopeFree XFOR Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold Stocks in the S&P
10 Most Overbought Stocks in the S&P
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: The Importance of Market Cap

If the video does not load after a few moments, Upgrade to the Latest Flash Player.
X4 Pharmaceuticals (XFOR) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:

XGN Market Cap History
XLO Market Cap History
XLRN Market Cap History
XNCR Market Cap History
XOMA Market Cap History
XON Market Cap History
XRAY Market Cap History
YMAB Market Cap History
YMTX Market Cap History
YTEN Market Cap History
More Healthcare companies »


XFOR Market Cap History | www.MarketCapHistory.com | Copyright © 2017 - 2024, All Rights Reserved

Nothing in MarketCapHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
Wait! Don't leave yet.
Want to receive our latest research absolutely free?

Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.